Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-30

FDA Approved: PIOGLITAZONE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Pioglitazone hydrochloride from Aurobindo Pharma Limited, updating an already approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pioglitazone hydrochloride (Pioglitazone hydrochloride)

Snippet

SUPPL AP for PIOGLITAZONE HYDROCHLORIDE (PIOGLITAZONE HYDROCHLORIDE)